Center for Global Health Policy’s “Science Speaks”: Multi-country survey sheds light on drug-resistant tuberculosis treatment needs
Antigone Barton, senior editor and writer of “Science Speaks,” discusses a survey published in The Lancet Infectious Diseases that “shows a need for better understanding of the dynamics of drug-resistant [tuberculosis], including through tests that do not yet exist. The survey’s findings … show that tuberculosis that is resistant to the most common first-line drug may often also be resistant to a drug used in substitute therapies…” (7/11).